Invention Grant
US07709641B2 NK1 antagonists 有权
NK1拮抗剂

NK1 antagonists
Abstract:
A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
Public/Granted literature
Information query
Patent Agency Ranking
0/0